Market Cap

Evolva Holding SA Market Capitalization:

CHF20.4 Million

CHF as of July 1, 2023

US$22.8 Million

business Evolva Holding SA Company Profile

Evolva Holding SA Main Stock Listing

show_chart SIX: EVE

Market Capitalization History of Evolva Holding SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $329.83 B
Vertex Pharmaceuticals Incorporated $88.79 B
CSL Limited $85.00 B
Marinomed Biotech AG $84.73 B
Regeneron Pharmaceuticals, Inc. $78.88 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $428.70 B
Lilly $417.05 B
Johnson & Johnson $412.24 B
Novo Nordisk $329.83 B
Merck $275.82 B

Yearly evolution of Evolva Holding SA market cap

Date Market Cap YoY Change
Jan. 1, 2023 CHF104.7 M -29.78%
Jan. 1, 2022 CHF149.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Evolva Holding SA Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

Evolva Holding SA has the following listings and related stock indices.


Stock: SIX: EVE

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.